Czechia, Jan. 13 -- Czechia based Bristol-Myers Squibb spol. s r.o. has secured contract from Fakultni nemocnice Plzen for Antineoplastic and immunomodulating agents - Medicinal preparation for autologous cell therapy - lisocabtagen maraleucel - 2025. The value of the contract is worth 13838640000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....